Crystallized Phenol Treatment in Postoperative Recurrent Pilonidal Disease

• Main Authors: Zülfü Bayhan, Sezgin Zeren, Şükrü Aydın Düzgün
• Format: Article
• Language: English
• Published: Modestum Publishing LTD 2016-03-01
• Series: Journal of Clinical and Experimental Investigations
• Subjects: Recurrent pilonidal disease; crystallized phe­nol treatment
• Online Access: http://jceionline.org/upload/sayi/30/JCEI-01279.pdf

Objective: A variety of surgical and minimally invasive treatment options are available to treat pilonidal sinus disease. Recurrence after surgery is a major problem. In addition to the surgical treatment of post-surgical recur­rences, minimally invasive treatment methods are also available. In our study, we aimed to investigate the results of crystallized phenol application on patients who were admitted to our clinic with post-surgical pilonidal sinus re­currence. Methods: The data of 26 patients who were admitted to our clinic with postoperative pilonidal sinus recurrence and who were treated by crystallized phenol treatment were analyzed. Patients were evaluated in terms of age, gender, previous surgery, crystallized phenol application count, follow –up period and wound infection. Results: Data of 26 patients were analyzed.3 patients (11.5%) were admitted with recurrence after Modified Limberg surgery. 11 patients (42.3%) were admitted with recurrence after Limberg flap surgery and12 patients (46.15%) were admitted with recurrence after primary re­pair. 19 patients (73.02%) were treated by one time crys­tallized phenol application. 5 (19. 23%) patients under­went a second time application and provided treatment after the second application. The cure was achieved in 24 (92.3%) patients after repeated applications. Conclusion: Crystallized phenol application is a minimal­ly invasive treatment method that can be applied easily under local anesthesia. The method has a high success rate after repeated applications in patients with recur­rence after surgery and is a very good alternative to sur­gical therapy. J Clin Exp Invest 2016; 7 (1): 19-22